There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:CS1 errors: PMID
Jump to navigation
Jump to search
Pages in category "CS1 errors: PMID"
The following 200 pages are in this category, out of 1,436 total.
(previous page) (next page)B
- Botulism overview
- Bovine spongiform encephalopathy classification
- Breast implant
- Breast lumps causes
- Brodie abscess MRI
- Brodie abscess natural history, complications and prognosis
- Brodie abscess pathophysiology
- Brodie abscess risk factors
- Bronchogenic cyst pathophysiology
- Buprenorphine (injection)
- Burn electrocardiogram
- Burn epidemiology and demographics
- Burn medical therapy
- Burn natural history, complications and prognosis
- Burnout (psychology)
C
- C4 glomerulopathy physical examination
- CA12
- CAAT box gene transcriptions
- Calcineurin-responsive transcription factor gene transcriptions
- Calponin 1
- Calponin 2
- Calponin 3, acidic
- Cancer natural history, complications and prognosis
- Candida auris infection
- Cannabis (drug) detailed information
- Capillary leak syndrome cost-effectiveness of therapy
- Capillary leak syndrome differential diagnosis
- Caplans syndrome epidemiology and demographics
- Caplans syndrome laboratory findings
- Caplans syndrome physical examination
- Caplans syndrome risk factors
- Cardiac resynchronization therapy indications
- Cardiac surgery
- Cardiac tamponade surgery
- Cardiac tumors diagnostic study of choice
- Cardiac tumors history and symptoms
- Cardiac tumors laboratory tests
- Cardiomyopathy 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy
- Cardiomyopathy 2023 ESC Guideline Recommendations
- Cardiomyopathy Guidelines
- Cardiovascular disease
- Carnett's test
- CASS4
- Cat8p gene transcriptions
- Cauda equina syndrome
- Cavernous angioma epidemiology and demographics
- Cavernous angioma future or investigational therapies
- Cavernous angioma historical perspective
- Cavernous angioma medical therapy
- Cavernous angioma MRI
- Cavernous angioma natural history, complications and prognosis
- Cavernous angioma other diagnostic studies
- Cavernous angioma physical examination
- Ceftriaxone
- Cell cycle regulation gene transcriptions
- Cellulitis physical examination
- Cerebral venous sinus thrombosis history and symptoms
- Cervical cancer screening
- Chagas disease echocardiography and ultrasound
- Chest pain classification
- Chest pain CT scan
- Chest pain diagnostic study of choice
- Chest pain differential diagnosis
- Chest pain electrocardiogram
- Chest pain history and symptoms
- Chest pain in children
- Chest pain MRI
- Chest pain natural history, complications and prognosis
- Chest pain other diagnostic studies
- Chest pain other imaging findings
- Chest pain physical examination
- Chest pain risk factors
- Chest pain surgery
- Chest pain x ray
- Childhood obesity
- Chlamydia infection laboratory findings
- Chlamydia infection medical therapy
- Chlamydia infection secondary prevention
- Cholesterol emboli syndrome pathophysiology
- Chondrodermatitis nodularis chronica helicis
- Chorioamnionitis future or investigational therapies
- Chorioamnionitis laboratory findings
- Chorioamnionitis medical therapy
- Chorioamnionitis MRI
- Chorioamnionitis pathophysiology
- Chronic hypertension blood pressure measurement
- Chronic hypertension differential diagnosis
- Chronic hypertension medical therapy
- Chronic hypertension medical therapy blood pressure goals of treatment
- Chronic hypertension pathophysiology
- Chronic myelogenous leukemia
- Chronic myelogenous leukemia causes
- Chronic myelogenous leukemia chest x ray
- Chronic myelogenous leukemia classification
- Chronic myelogenous leukemia CT
- Chronic myelogenous leukemia differential diagnosis
- Chronic myelogenous leukemia epidemiology and demographics
- Chronic myelogenous leukemia historical perspective
- Chronic myelogenous leukemia history and symptoms
- Chronic myelogenous leukemia laboratory tests
- Chronic myelogenous leukemia medical therapy
- Chronic myelogenous leukemia MRI
- Chronic myelogenous leukemia natural history
- Chronic myelogenous leukemia other diagnostic studies
- Chronic myelogenous leukemia overview
- Chronic myelogenous leukemia pathophysiology
- Chronic myelogenous leukemia physical examination
- Chronic myelogenous leukemia primary prevention
- Chronic myelogenous leukemia risk factors
- Chronic myelogenous leukemia screening
- Chronic myelogenous leukemia secondary prevention
- Chronic myelogenous leukemia staging
- Chronic myelogenous leukemia surgery
- Chronic myelogenous leukemia ultrasound
- Chronic neutrophilic leukemia differential diagnosis
- Chronic obstructive pulmonary disease medical therapy
- Chronic pain medical therapy
- Chronic pelvic pain
- Chronic pelvic pain resident survival guide
- Chronic renal failure causes
- Chronic renal failure historical perspective
- Chronic renal failure medical therapy
- Chronic renal failure pathophysiology
- Chronic stable angina revascularization percutaneous coronary intervention
- Chronic total occlusions
- Ciprofloxacin (oral)
- Circadian control element gene transcriptions
- Clinic
- Cohort study
- Collateral circulation
- Colorectal cancer screening
- Commotio cordis echocardiography or ultrasound
- Commotio cordis electrocardiogram
- Commotio cordis other diagnostic studies
- Commotio cordis other imaging findings
- Commotio cordis primary prevention
- Commotio cordis risk factors
- Community-acquired pneumonia classification
- Community-acquired pneumonia medical therapy
- Community-acquired pneumonia physical examination
- Comorbidity
- Complex locus A1BG and ZNF497
- Complications Based Questions
- Congenital diaphragmatic hernia causes
- Congenital diaphragmatic hernia differential diagnosis
- Congenital diaphragmatic hernia epidemiology and demographics
- Congenital diaphragmatic hernia laboratory findings
- Congenital diaphragmatic hernia medical therapy
- Congenital diaphragmatic hernia natural history, complications and prognosis
- Congenital diaphragmatic hernia pathophysiology
- Congenital diaphragmatic hernia physical examination
- Congenital diaphragmatic hernia risk factors
- Congenital diaphragmatic hernia screening
- Congenital diaphragmatic hernia secondary prevention
- Congenital diaphragmatic hernia surgery
- Congenital Toxoplasmosis
- Congestive heart failure ACE inhibitors
- Congestive heart failure acute pharmacotherapy
- Congestive heart failure AHA recommendations Coordinating Care for Patients With Chronic HF
- Congestive heart failure AHA recommendations for hospitalized patient
- Congestive heart failure AHA recommendations for patients with a prior MI
- Congestive heart failure AHA recommendations Quality Metrics/Performance Measures
- Congestive heart failure aldosterone antagonists
- Congestive heart failure and obstructive sleep apnea
- Congestive heart failure angiotensin receptor blockers
- Congestive heart failure angiotensin receptor-neprilysin inhibitor
- Congestive heart failure antiarrhythmic drugs
- Congestive heart failure beta blockers
- Congestive heart failure calcium channel blockers
- Congestive heart failure cardiac catheterization
- Congestive heart failure cardiac MRI
- Congestive heart failure chest x ray
- Congestive heart failure chronic pharmacotherapy
- Congestive heart failure classification
- Congestive heart failure clinical assessment
- Congestive heart failure diuretics
- Congestive heart failure drugs to avoid
- Congestive heart failure echocardiography
- Congestive heart failure electrocardiogram
- Congestive heart failure end-of-life considerations
- Congestive heart failure epidemiology and demographics
- Congestive heart failure exercise stress testing
- Congestive heart failure history and symptoms
- Congestive heart failure implantation of intracardiac defibrillator
- Congestive heart failure iron
- Congestive heart failure laboratory tests
- Congestive heart failure left ventricular assist devices
- Congestive heart failure Management of Acute heart failure
- Congestive heart failure myocardial viability study
- Congestive heart failure natural history
- Congestive heart failure other pharmacotherapies
- Congestive heart failure pharmacotherapy
- Congestive heart failure physical examination
- Congestive heart failure positive inotropics
- Congestive heart failure risk factors
- Congestive heart failure Sodium-glucose co-transporter 2 inhibitors
- Congestive heart failure treatment of associated conditions
- Congestive heart failure Treatment of Heart failure with preserved ejection fraction
- Congestive heart failure treatment of patients at high risk for developing heart failure (Stage A)
- Congestive heart failure treatment of patients who have concomitant disorders
Media in category "CS1 errors: PMID"
The following 2 files are in this category, out of 2 total.
-
Cochrane.2020.pmid.32584464.png 596 × 407; 19 KB
-
COVID-19 - Dx testing.png 475 × 333; 15 KB